U.S. Healthcare Services Stock News

American Healthcare REIT, Inc. recently acquired six senior housing communities from Kensington Senior Living for approximately US$572 million, the first phase of an eight-community, 745-unit portfolio with a total contract price of about US$873 million, while Kensington continues to operate the properties. An interesting angle is that these assisted living and memory care communities sit in affluent, hard-to-build infill markets like Los Angeles, the San Francisco Bay Area, Washington,...

Escalating U.S. Section 338 tariffs on Canadian goods are shaking up cross border supply chains and forcing buyers to look closer to home. That shift can create fresh winners, especially among U.S. listed manufacturers that already produce electronics, appliances, tools and hardware domestically. This article walks through three stocks exposed to the latest trade headlines and explains how the news could matter for your portfolio decisions. The three stocks covered below are just a starting...

Bandwidth (BAND) has drawn fresh attention after a strong recent run in the stock, with the share price up 4.9% over the past day and about 30% over the past month. Viewed over a longer stretch, Bandwidth’s share price has a 1-year year-to-date return of 257.17% and a 1-year total shareholder return of 233.05%. However, the share price fell 22.58% over the past 90 days, which suggests strong momentum has recently cooled. Compare Bandwidth’s surge with other fast movers in the market by...

In the recent past, Rush Street Interactive reported a record second quarter, with all-time highs in revenue and Adjusted EBITDA that exceeded analyst expectations, and the company raised its full-year revenue and EBITDA guidance on the back of its online casino and sports betting operations. This combination of operational records and a higher outlook highlights how RSI’s business model is scaling, even as investor reaction remained cautious. Next, we’ll examine how RSI’s record quarterly...

Why recent contracts and AI tools matter for Leidos Holdings stock Leidos Holdings (LDOS) has attracted fresh attention after securing two U.S. military contracts focused on cyber defense and behavioral health, alongside launching an AI-enabled geospatial intelligence tool aimed at faster, more accurate mapping. Together, these developments highlight how Leidos Holdings is positioned across cybersecurity, defense health research, and AI driven software, areas that many investors track closely...

BellRing Brands (BRBR) is under fresh legal scrutiny as several investor rights law firms investigate potential fiduciary duty breaches by directors and officers following allegations of financial misstatements and a revised sales outlook under new leadership. The legal pressure has come at a difficult time for BellRing Brands, with the share price down 16.79% over the past 30 days. This has contributed to a 60.48% year to date share price decline and a 75.23% fall in 1 year total shareholder...

Freshpet (FRPT) has drawn investor attention after recent share price moves, with the stock closing at $70.31. The company’s returns over the past month and past 3 months now look very different. Over the past year, Freshpet’s total shareholder return of 28.58% contrasts with a longer-term 5-year total shareholder return that is down 46.20%. At the same time, the strong 90-day share price return of 40.62% suggests momentum has recently picked up as investors reassess growth potential and...

Despite the fact that Alset Inc.'s (NASDAQ:AEI) value has dropped 12% in the last week insiders who sold US$2.7m worth...

Artificial intelligence is revolutionizing the wireless electric vehicle charging sector, enhancing efficiency and driving massive infrastructure investment. AI technologies are significantly improving wireless charging efficiency to over 93% by optimizing vehicle positioning and predictive maintenance, thus reducing energy loss and costs. Large-scale investments, such as the $500 billion Stargate Project and Europe’s $215.3 billion InvestAI initiative, are channeling substantial capital into...

Insiders who bought US$14.6m worth of Pluri Inc.'s ( NASDAQ:PLUR ) stock at an average buy price of US$3.17 over the...

Illumina stock has delivered a sharp 111.7% gain over the past year, yet valuation checks send mixed signals as an intrinsic value estimate points to meaningful upside while market multiples lean the other way. For investors, that split raises the question of how much of the recent optimism is already reflected in the current US$207.13 share price. The 111.7% return over 1 year may indicate a strong rebound in sentiment that can leave less room for error if expectations ease. Future growth...

Recent performance snapshot for CECO Environmental CECO Environmental (CECO) has drawn attention after a recent share price move, with the stock closing at $70.55 on 30 August 2026. That level anchors how investors may frame its recent returns. Set against that latest move, CECO Environmental has a 30 day share price return of about 7%, while the share price over the past quarter is down around 11%. At the same time, total shareholder return over the last year is about 55%, and the five year...

Recent Stock Performance Ahead of Q2 2027 Earnings Ollie's Bargain Outlet Holdings (OLLI) is set to report Q2 2027 results before the market opens on Wednesday, with investors watching closely after the previous quarter's margin outperformance and revenue shortfall. The stock has retreated in the lead up to this announcement. It is down 4.1% over the past day, 3% over the past week, and about 1.5% over the past month. That weakness extends over longer periods. Ollie's Bargain Outlet Holdings...

In recent months, PepsiCo has faced warehouse job cuts tied to outsourcing in South Carolina, conflict-related damage at a production facility in Ukraine, and scrutiny over third-party supply-chain controls after expired products were allegedly relabeled by external partners in India. These developments highlight how PepsiCo’s efforts to modernize logistics and protect its brands are being tested by external disruptions and operational reshaping across key markets. We’ll now examine how...

Geopolitics is reshaping where energy, food and critical minerals are produced and processed, as China, the US and Europe argue over trade rules, overcapacity and control of key resources. That shift is pushing capital toward supply chains that governments want closer to home, which many investors risk overlooking. This article explores that trend and profiles three stocks that appear closely exposed to these developments. The three stocks in this article are just a starting sample, and the...

Helios Technologies (HLIO) is back on investor radars after its Electronics segment expanded the No Roads platform with Apple CarPlay and Android Auto integration, targeting connected experiences in marine, powersports, and specialty vehicles. Despite the product update, Helios Technologies’ share price has come under pressure in the short term, with the 1-month share price return down 9.6% and the 3-month share price return down 17.2%. However, the year-to-date share price return of 28.8%...

MGE Energy (MGEE) just approved a 7.0% increase in its regular quarterly dividend to $0.5083 per share, extending the utility’s record to 51 consecutive years of dividend growth for shareholders. MGE Energy’s share price has been softer in the near term, with the 30 day share price return down 2.6% at a latest share price of $77.45. However, the 90 day share price return of 5.5% and a 3 year total shareholder return of 17.1% point to steadier long term momentum. Compare MGE Energy’s dividend...

Gilead Sciences (GILD) has drawn fresh investor attention after two recent regulatory decisions. The FDA approved Bixlenvo for virologically suppressed adults with HIV, and the European Commission cleared Trodelvy plus Keytruda for certain metastatic triple-negative breast cancer patients. These approvals arrive after a strong run in Gilead Sciences' stock, with a 30-day share price return of 15.14% and a year-to-date share price return of 23.29%, alongside a 36.48% 1-year total shareholder...

Zacks recently compared Clorox (CLX) with Ahold NV and assigned Clorox a weaker rank and lower value grade. This contrast has renewed attention on whether Clorox stock still appeals to value-focused investors. Clorox shares have come under pressure recently, with a 7 day share price return down 9.5% and a 1 day move down 2.8%, even though the 90 day share price return is up 7.3%. Over longer periods, total shareholder returns over 1, 3 and 5 years have been negative. This suggests recent...

Power Integrations has had a tough long term share price record, yet the stock still screens as expensive on broad valuation checks. Recent pullbacks may look tempting, but the current market pricing does not line up as a clear bargain. The stock has fallen 51.5% over 5 years, which means long term holders have seen a significant erosion in value despite the company remaining firmly on investors' radar. Future revenue and earnings growth expectations from Power Integrations' power conversion...

BioNTech (NasdaqGS:BNTX) has halted a Phase 2 trial of its individualized mRNA cancer immunotherapy autogene cevumeran in high risk colorectal cancer after an independent Data Safety Monitoring Board recommended stopping the study for futility. BioNTech’s recent news flow mixes setbacks and progress, with the termination of this colorectal cancer trial arriving shortly after fresh lung cancer data and an FDA approval for the updated COMIRNATY XFG COVID-19 vaccine. The 7 day share price return...

Mirum Pharmaceuticals stock triggered by recent performance metrics Mirum Pharmaceuticals (MIRM) has drawn fresh attention after recent performance metrics highlighted a mix of strong multi year returns and short term share price softness, prompting investors to reassess the stock at around $98 per share. The company reports annual revenue of about $618 million and a net loss of roughly $860 million. Recent total returns are up over the past year and past 3 years, while the past month shows a...

Insiders seem to have made the most of their holdings by selling US$259k worth of Cartesian Therapeutics, Inc...

Genpact (G) stock is in focus after the company launched its Genpact Record-to-Report Suite, an agentic AI platform for finance teams, and appointed Priya Vijayarajendran as Chief Product and Platform Officer. Against this backdrop, Genpact's recent agentic AI push comes after a sharp reset in the stock earlier in the year, with the year to date share price return down 17.9%, even as momentum has picked up with a 30 day share price return of 7.2% and a 90 day share price return of 16.7%. Over...